US Stock MarketDetailed Quotes

CYTH Cyclo Therapeutics

Watchlist

1.350
+0.090+7.14%

Trading Apr 29 10:15 ET

38.77MMarket Cap-1097P/E (TTM)

Cyclo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-7.08%-16.19M

-56.36%-4.29M

-27.02%-4.04M

20.14%-3.48M

9.52%-4.37M

-0.73%-15.11M

-5.17%-2.75M

-5.11%-3.18M

1.90%-4.36M

1.96%-4.83M

Net income from continuing operations

-29.81%-20.06M

-13.29%-5.64M

-12.35%-4.77M

-34.31%-4.64M

-80.66%-5.01M

-8.15%-15.45M

-78.36%-4.98M

-10.02%-4.25M

4.04%-3.45M

31.34%-2.77M

Operating gains losses

----

---158.52K

--0

---158.52K

Depreciation and amortization

-1.05%19.28K

-1.05%4.82K

-6.04%4.82K

1.65%4.82K

15.77%19.48K

15.76%4.87K

21.92%5.13K

-2.51%4.74K

33.55%4.74K

Change In working capital

6,461.58%3.06M

-50.72%1.03M

-45.65%523.3K

191.92%967.49K

126.33%540.36K

96.08%-48.15K

479.41%2.09M

103.51%962.74K

5.92%-1.05M

-117.43%-2.05M

-Change in receivables

-115.75%-67.39K

-41.02%181.38K

-680.24%-215.37K

114.69%42.83K

-120.34%-76.23K

196.36%427.85K

292.01%307.55K

121.53%37.12K

-2,659.13%-291.56K

471.59%374.74K

-Change in inventory

-95.10%-52.78K

-685.84%-97.52K

355.49%26.89K

119.85%7.85K

56.62%9.99K

-358.35%-27.05K

-36.85%16.65K

-169.54%-10.52K

-256.50%-39.56K

132.03%6.38K

-Change in prepaid assets

74.12%-64.32K

-28.79%826.21K

16.89%185.21K

-1,497.92%-678.85K

75.44%-396.91K

79.33%-248.56K

825.37%1.16M

-40.64%158.45K

138.04%48.56K

-36.71%-1.62M

-Change in payables and accrued expense

1,719.66%3.25M

-80.03%121.79K

-32.15%526.41K

307.31%1.6M

222.73%1M

-149.09%-200.39K

-6.96%609.81K

113.40%775.82K

20.60%-769.61K

-327.69%-816.4K

-Change in other working capital

--2.04K

--154

--155

144.93%155

202.34%1.57K

----

---345

-1,413.68%-1.54K

Cash from discontinued investing activities

Operating cash flow

-7.08%-16.19M

-56.36%-4.29M

-27.02%-4.04M

20.14%-3.48M

9.52%-4.37M

-0.73%-15.11M

-5.17%-2.75M

-5.11%-3.18M

1.90%-4.36M

1.96%-4.83M

Investing cash flow

Cash flow from continuing investing activities

-106.34%-2.42K

-2.42K

157.52%38.17K

168.02%18.28K

286.79%10.58K

179.59%9.32K

Net PPE purchase and sale

83.96%-2.42K

---2.42K

--0

32.95%-15.09K

--0

---10.49K

--0

---4.6K

Net other investing changes

----

42.69%53.26K

--0

321.79%28.76K

-37.17%10.58K

317.65%13.92K

Cash from discontinued investing activities

Investing cash flow

-106.34%-2.42K

---2.42K

--0

157.52%38.17K

--0

168.02%18.28K

286.79%10.58K

179.59%9.32K

Financing cash flow

Cash flow from continuing financing activities

352,373.00%23.89M

11.74M

3.41M

55,107.98%3.74M

-99.96%6.78K

-99.91%6.78K

Net issuance payments of debt

--0

200.00%6.78K

--0

--6.78K

Net common stock issuance

--9.74M

--509.73K

--5M

--2.9M

--1.33M

--0

----

Proceeds from stock option exercised by employees

--4.8M

--1.88M

--1.48K

--509.79K

--2.41M

--0

Net other financing activities

--9.35M

----

Cash from discontinued financing activities

Financing cash flow

352,373.00%23.89M

--11.74M

--5M

--3.41M

55,107.98%3.74M

-99.96%6.78K

--0

-99.91%6.78K

Net cash flow

Beginning cash position

-90.71%1.54M

-58.00%1.8M

-88.71%841.53K

-92.24%915.18K

-90.71%1.54M

29.32%16.61M

-49.18%4.29M

-34.98%7.45M

-23.91%11.8M

29.32%16.61M

Current changes in cash

151.12%7.7M

371.04%7.44M

130.36%960.28K

98.31%-73.65K

86.95%-628.24K

-500.08%-15.07M

-133.61%-2.75M

-4.68%-3.16M

-7.46%-4.35M

-280.94%-4.81M

End cash Position

499.10%9.25M

-58.00%1.8M

-88.71%841.53K

-92.24%915.18K

-90.71%1.54M

-49.18%4.29M

-34.98%7.45M

-23.91%11.8M

Free cash flow

-6.99%-16.19M

-56.45%-4.3M

-26.61%-4.04M

20.14%-3.48M

9.61%-4.37M

-0.68%-15.13M

-5.17%-2.75M

-5.45%-3.19M

2.39%-4.36M

1.87%-4.83M

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-7.08%-16.19M	-56.36%-4.29M	-27.02%-4.04M	20.14%-3.48M	9.52%-4.37M	-0.73%-15.11M	-5.17%-2.75M	-5.11%-3.18M	1.90%-4.36M	1.96%-4.83M
Net income from continuing operations	-29.81%-20.06M	-13.29%-5.64M	-12.35%-4.77M	-34.31%-4.64M	-80.66%-5.01M	-8.15%-15.45M	-78.36%-4.98M	-10.02%-4.25M	4.04%-3.45M	31.34%-2.77M
Operating gains losses	----	----	----	----	----	---158.52K	--0	--0	--0	---158.52K
Depreciation and amortization	-1.05%19.28K	-1.05%4.82K	-6.04%4.82K	1.65%4.82K	1.65%4.82K	15.77%19.48K	15.76%4.87K	21.92%5.13K	-2.51%4.74K	33.55%4.74K
Change In working capital	6,461.58%3.06M	-50.72%1.03M	-45.65%523.3K	191.92%967.49K	126.33%540.36K	96.08%-48.15K	479.41%2.09M	103.51%962.74K	5.92%-1.05M	-117.43%-2.05M
-Change in receivables	-115.75%-67.39K	-41.02%181.38K	-680.24%-215.37K	114.69%42.83K	-120.34%-76.23K	196.36%427.85K	292.01%307.55K	121.53%37.12K	-2,659.13%-291.56K	471.59%374.74K
-Change in inventory	-95.10%-52.78K	-685.84%-97.52K	355.49%26.89K	119.85%7.85K	56.62%9.99K	-358.35%-27.05K	-36.85%16.65K	-169.54%-10.52K	-256.50%-39.56K	132.03%6.38K
-Change in prepaid assets	74.12%-64.32K	-28.79%826.21K	16.89%185.21K	-1,497.92%-678.85K	75.44%-396.91K	79.33%-248.56K	825.37%1.16M	-40.64%158.45K	138.04%48.56K	-36.71%-1.62M
-Change in payables and accrued expense	1,719.66%3.25M	-80.03%121.79K	-32.15%526.41K	307.31%1.6M	222.73%1M	-149.09%-200.39K	-6.96%609.81K	113.40%775.82K	20.60%-769.61K	-327.69%-816.4K
-Change in other working capital	--2.04K	--154	--155	144.93%155	202.34%1.57K	----	----	----	---345	-1,413.68%-1.54K
Cash from discontinued investing activities
Operating cash flow	-7.08%-16.19M	-56.36%-4.29M	-27.02%-4.04M	20.14%-3.48M	9.52%-4.37M	-0.73%-15.11M	-5.17%-2.75M	-5.11%-3.18M	1.90%-4.36M	1.96%-4.83M
Investing cash flow
Cash flow from continuing investing activities	-106.34%-2.42K	-2.42K	0	0	0	157.52%38.17K	0	168.02%18.28K	286.79%10.58K	179.59%9.32K
Net PPE purchase and sale	83.96%-2.42K	---2.42K	--0	--0	--0	32.95%-15.09K	--0	---10.49K	--0	---4.6K
Net other investing changes	----	----	----	----	----	42.69%53.26K	--0	321.79%28.76K	-37.17%10.58K	317.65%13.92K
Cash from discontinued investing activities
Investing cash flow	-106.34%-2.42K	---2.42K	--0	--0	--0	157.52%38.17K	--0	168.02%18.28K	286.79%10.58K	179.59%9.32K
Financing cash flow
Cash flow from continuing financing activities	352,373.00%23.89M	11.74M	5M	3.41M	55,107.98%3.74M	-99.96%6.78K	0	0	0	-99.91%6.78K
Net issuance payments of debt	--0	--0	--0	--0	--0	200.00%6.78K	--0	--0	--0	--6.78K
Net common stock issuance	--9.74M	--509.73K	--5M	--2.9M	--1.33M	--0	--0	--0	----	----
Proceeds from stock option exercised by employees	--4.8M	--1.88M	--1.48K	--509.79K	--2.41M	--0	--0	--0	--0	--0
Net other financing activities	--9.35M	----	----	----	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	352,373.00%23.89M	--11.74M	--5M	--3.41M	55,107.98%3.74M	-99.96%6.78K	--0	--0	--0	-99.91%6.78K
Net cash flow
Beginning cash position	-90.71%1.54M	-58.00%1.8M	-88.71%841.53K	-92.24%915.18K	-90.71%1.54M	29.32%16.61M	-49.18%4.29M	-34.98%7.45M	-23.91%11.8M	29.32%16.61M
Current changes in cash	151.12%7.7M	371.04%7.44M	130.36%960.28K	98.31%-73.65K	86.95%-628.24K	-500.08%-15.07M	-133.61%-2.75M	-4.68%-3.16M	-7.46%-4.35M	-280.94%-4.81M
End cash Position	499.10%9.25M	499.10%9.25M	-58.00%1.8M	-88.71%841.53K	-92.24%915.18K	-90.71%1.54M	-90.71%1.54M	-49.18%4.29M	-34.98%7.45M	-23.91%11.8M
Free cash flow	-6.99%-16.19M	-56.45%-4.3M	-26.61%-4.04M	20.14%-3.48M	9.61%-4.37M	-0.68%-15.13M	-5.17%-2.75M	-5.45%-3.19M	2.39%-4.36M	1.87%-4.83M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall